Invention Grant
- Patent Title: Crystaline forms of HCV inhibitor
- Patent Title (中): HCV抑制剂的晶体形式
-
Application No.: US13939873Application Date: 2013-07-11
-
Publication No.: US09469673B2Publication Date: 2016-10-18
- Inventor: Ahmad Y. Sheikh , Moiz Diwan , Agnes E. Pal , Yuchuan Gong , Paul J. Brackemeyer , Geoff Zhang , Seble Wagaw
- Applicant: AbbVie Inc.
- Applicant Address: US IL North Chicago
- Assignee: AbbVie Inc.
- Current Assignee: AbbVie Inc.
- Current Assignee Address: US IL North Chicago
- Agency: Foley Hoag LLP
- Agent Dana M. Gordon
- Main IPC: C07K5/083
- IPC: C07K5/083 ; C07K5/12 ; C07D487/04
Abstract:
The present invention features crystalline forms of Compound I. In one embodiment, a crystalline form of Compound I has characteristic peaks in the PXRD pattern at values of two theta (° 2θ) of 10.7, 11.6, 12.7, 13.0, 13.2, 13.7, 14.5, 18.7, 19.0, and 19.9 after equilibration at 43% relative humidity.
Public/Granted literature
- US20140018518A1 CRYSTALINE FORMS OF HCV INHIBITOR Public/Granted day:2014-01-16
Information query
